Provectus Biopharmaceuticals Inc (NYSE MKT LLC:PVCT)

0.80
Delayed Data
As of May 22
 -0.0269 / -3.25%
Today’s Change
0.30
Today|||52-Week Range
2.10
0.00%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Provectus Biopharmaceuticals Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +337.50% increase from the last price of 0.80.

Analyst Recommendations

There are no recommendations available.

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
$0.00
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually 36.36%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account